BusinessNew Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific SessionBy Nasdaq OMXMar 14, 2018, 12:01 PM UTC
